These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9862079

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
    Paronis CA, Holtzman SG.
    Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
    [Abstract] [Full Text] [Related]

  • 24. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
    Preston KL, Bigelow GE.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):813-23. PubMed ID: 7679737
    [Abstract] [Full Text] [Related]

  • 25. Cocaine-opioid interactions in groups of rats trained to discriminate different doses of cocaine.
    Kantak KM, Riberdy A, Spealman RD.
    Psychopharmacology (Berl); 1999 Dec; 147(3):257-65. PubMed ID: 10639683
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure.
    Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR.
    Exp Clin Psychopharmacol; 1998 May; 6(2):169-78. PubMed ID: 9608349
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users.
    Levy-Cooperman N, Schoedel KA, Reiz JL, Thompson D, Chakaraborty B, Geoffroy P, Michalko KJ.
    J Opioid Manag; 2016 May; 12(3):165-80. PubMed ID: 27435437
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Morphine discriminative control is mediated by the mu opioid receptor: assessment of delta opioid substitution and antagonism.
    Stevenson GW, Cañadas F, Zhang X, Rice KC, Riley AL.
    Pharmacol Biochem Behav; 2000 Aug; 66(4):851-6. PubMed ID: 10973525
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
    Negus SS, Mello NK.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.